The clinical features, treatment, and prognostic factors for peripheral T‐cell lymphomas: A single‐institution analysis of 240 Chinese patients-Reference-Cited by-同舟云学术

The clinical features, treatment, and prognostic factors for peripheral T‐cell lymphomas: A single‐institution analysis of 240 Chinese patients

Published:2022-07-12 Issue: Volume: Page:
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clncl Oncology

Author:

Chen Haizhu¹,Tao Yunxia¹,Zhou Yu¹,Liu Peng¹,Yang Jianliang¹,He Xiaohui¹,Zhou Shengyu¹,Qin Yan¹,Song Yongwen²,Gui Lin¹,Zhang Changgong¹,Yang Sheng¹,Shi Yuankai¹^ORCID

Affiliation:

1. Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs Beijing China

2. Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13831

Reference60 articles.

1. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma

2. International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes

3. The 2016 revision of the World Health Organization classification of lymphoid neoplasms

4. Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

5. Outcomes and Prognostic Factors in Angioimmunoblastic T cell Lymphoma: Final Report from the International TCell Project

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase 2 study of pegylated liposomal doxorubicin plus cyclophosphamide, vincristine/vindesine, and prednisone in newly diagnosed PTCL: 8-year results;The Oncologist;2024-05-31

2. T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival;Asia-Pacific Journal of Clinical Oncology;2023-08-27

3. Baseline Serum Albumin Levels for Predicting Progression-free Survival in Patients with Non-Hodgkin Lymphoma: A Single-center Prospective Study in Syria;Journal of Applied Hematology;2023

4. ALK-Positive Anaplastic Large-Cell Lymphoma in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review;OncoTargets and Therapy;2022-10